AS
Ajmal Shah Shah Akil Ali
About Ajmal Shah Shah Akil Ali
Data last updated:
Ajmal Shah Shah Akil Ali is a Managing Director at Wansol Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Wansol Pharmaceuticals Private Limited reported revenue of ₹14.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wansol Pharmaceuticals Private Limited U47721MH2023PTC405257 | Managing Director | 22 Jun 2023 | 2023 | ₹14.1 Lakh (FY 2025) | Active |
Board colleagues of Ajmal Shah Shah Akil Ali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Awais Khan Naim Khan | 10210453 | Wansol Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajmal Shah Shah Akil Ali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajmal Shah Shah Akil Ali
Ajmal Shah Shah Akil Ali currently holds 1 directorship: Wansol Pharmaceuticals Private Limited (Managing Director, since 22 Jun 2023, revenue ₹14.1 Lakh (FY 2025)).
Ajmal Shah Shah Akil Ali was first appointed on 22 Jun 2023 as Managing Director at Wansol Pharmaceuticals Private Limited.
The current boards of Ajmal Shah Shah Akil Ali's companies include Awais Khan Naim Khan (Wansol Pharmaceuticals Private Limited).